This treatment applies to the following species:
Ehrlichia Risticii Bacterin
EQUINE POTOMAVAC® is a liquid suspension of inactivated Ehrlichia risticii. Safety and efficacy of this product have been demonstrated in controlled vaccination challenge tests and in thorough field evaluations.
Recommended for the vaccination of healthy horses as an aid in the prevention of Potomac Horse Fever (equine monocytic ehrlichiosis) caused by E. risticii.
For primary vaccination, aseptically inject 1 mL (1 dose) intramuscularly into healthy horses 3 months of age or older. Revaccinate with a second 1 mL dose 3 to 4 weeks later. Revaccinate annually with a single 1 mL dose.
Store at 2-7°C (35-45°F). Do not freeze. Use entire contents when first opened. Shake well before using. Contains gentamicin as a preservative. Do not vaccinate within 21 days prior to slaughter. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. Vaccinating animals whose immune response is compromised by stress, disease, etc. may not produce the desired results.
SOLD TO VETERINARIANS ONLY.
For Veterinary Use Only.
®POTOMAVAC is a registered trademark of MERIAL.
Manufactured By MERIAL INC., Athens, GA 30601 USA
U.S. Vet. Lic. No. 298
Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, Qc, H9X 3V1
5 x 1 Dose (1 mL)
3 x 10 Dose (10 mL)
3239 SATELLITE BLVD., DULUTH, GA, 30096
Every effort has been made to ensure the accuracy of the Equine POTOMAVAC information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert